| gucci sale |
The Chinese government has welcomed the move to include
chowmein as a prescription drug and to subsequently shift it
from the food and beverages industry to the pharmaceuticals
industry. A spokesperson of Chinese export promotion council
said Chinese firms will now export ready-to-eat authentic
packaged chowmein to pharmaceutical importers in India after
procuring the necessary licences for medical exports.
Authentic Chinese chowmein will come with a list of
ingredients and cautionary warnings, and would be sold only
against prescription from a medical practitioner since the
authentic drug will be more potent, the trade body
representative added.
Companies like Nestle and Nissin Foods, manufacturers of the
popular instant noodles brands like Maggi and Top Ramen,
however, are worried about the developments since this would
now shrink their target market encompassing children and
young adults and would now need to be retailed only at
pharmaceutical outlets for adults who have a medical
prescription for the same. They were also concerned that
advertisements for their products would also be restricted
like those for alcohol and tobacco products.
While the repercussions on the food and beverage industry are
obvious, pharmaceutical companies Ranbaxy, Cipla, Sun
Pharmaceutical Industries and Cadila Healthcare, which have
been manufacturing Indian brands of Viagra, have now stopped
production and have shifted focus to manufacturing packaged
chowmein and are setting up factories for the same. Chefs
from five star hotels specializing in Oriental cuisine are
being hired to prepare excellent and authentic chowmein to
replace Viagra. Fresh investments are being made to set up
state-of-the-art modular kitchens that would replace
laboratories and churn out packed and frozen chowmein that
one could heat and eat.
